The Guardian: Mergers & Acquisitions

DECEMBER 26, 2023

Gracell Biotechnologies acquisition marks China’s growing importance to the Anglo-Swedish drugmaker AstraZeneca has struck a deal to buy a Chinese cancer therapy company for up to $1.2bn (£950m), as Britain’s biggest drugmaker expands its footprint in its second-largest market.

Pharmaceutical 77

Pharmaceutical Acquisitions IT Mergers and Acquisitions 77

How2Exit

MARCH 31, 2024

Get the Insider Tips You Need to Secure Your Deal - Watch Here rn rn About the Guest(s): rn Patrick O'Connell is an experienced mergers and acquisitions (M&A) advisor with a profound depth of knowledge in buying and selling small businesses valued between one to $20 million. b' E200: Buying or Selling a Small Business?

Business 130

Business Mergers and Acquisitions Securities M&A 130

Wizenius

APRIL 27, 2023

One specific area where these laws are frequently applied is in the context of merger and acquisition transactions. To prevent this from happening, governments often have laws in place that regulate mergers and acquisitions to ensure that they do not create or enhance a monopoly or otherwise harm competition.

Mergers and Acquisitions 52

Mergers and Acquisitions Pharmaceutical Retail Acquisitions 52

InvestmentBank.com

AUGUST 14, 2019

The benefits of VR are not limited to language immersion, architecture, interior design, space expedition, biology, chemistry or pharmaceutical practices. They also have developed Daydream Labs where employees can be trained visually and interactively, resulting in a faster learning process [9].

Education 52

Education Mergers and Acquisitions Capital Investment 52

Cooley M&A

JANUARY 23, 2024

While the year saw an overall decline in M&A activity (down 17% from 2022) , total pharmaceuticals and life sciences deal value in 2023 increased by approximately 50% compared to 2022. billion; Bristol Myer Squibb’s acquisition of RayzeBio for $4.1 billion; and Roche’s acquisition of Carmot Therapeutics for up to $3.1

M&A 52

M&A Mergers and Acquisitions Pharmaceutical Acquisitions 52

The Harvard Law School Forum

JUNE 16, 2023

In recent months, the life sciences industry has seen the reemergence of contingent value rights, or CVRs, in public company acquisitions as a way to bridge a valuation gap between buyers and sellers. Executive Summary This study addresses CVRs, the public M&A analog to the earnout used in private deals, which can be price-driven (e.g.,

M&A 64

M&A Pharmaceutical Acquisitions Valuation 64

Benchmark International

APRIL 18, 2024

The healthcare sector is primarily segmented into pharmaceuticals, services, devices, and others. According to Verified Market Research, the global healthcare market will reach $665.37 billion by 2028. By application, the industry is categorized by cardiovascular, oncology, anti-infection, central nervous system, respiratory, and others.

Healthcare 59

Healthcare Medical Pharmaceutical Mergers and Acquisitions 59

Focus Investment Banking

OCTOBER 20, 2023

Washington, DC, (October 20, 2023) – FOCUS Investment Banking (“FOCUS”), a national middle market investment banking firm providing merger, acquisition, divestiture and corporate finance services, announced today that Bearing Distributors, Inc. Schrimsher, President & CEO for Applied. With locations across the U.S.

Investment Banking 52

Investment Banking Sale Banking Bank 52

The Harvard Law School Forum

JUNE 16, 2023

In recent months, the life sciences industry has seen the reemergence of contingent value rights, or CVRs, in public company acquisitions as a way to bridge a valuation gap between buyers and sellers. Executive Summary This study addresses CVRs, the public M&A analog to the earnout used in private deals, which can be price-driven (e.g.,

M&A 40

M&A Pharmaceutical Acquisitions Valuation 40

Devensoft

AUGUST 22, 2023

Understanding Freelance Modeling in M&A In the realm of mergers and acquisitions (M&A), freelance modeling emerges as a dynamic and adaptive methodology, offering a departure from traditional approaches. Illustrating this transformative power, consider a merger between a software giant and a cybersecurity startup.

M&A 52

M&A Business Mergers and Acquisitions Collaboration 52

Devensoft

JUNE 19, 2023

Mergers and acquisitions (M&A) constitute intricate and frequently risky transactions with significant implications for stakeholders. Here are some case studies of successful rationalization in M&A: Pfizer and Wyeth In 2009, Pfizer acquired Wyeth , a global pharmaceutical company, for $68 billion.

M&A 52

M&A Mergers and Acquisitions Mergers Management 52

Benchmark International

AUGUST 1, 2023

Benchmark International is pleased to announce the acquisition of Wicklow-based Paramount Packaging by Mediahuis Ireland, through its Reach Group subsidiary.

Retail 52

Retail Food Hospitality Pharmaceutical 52

Cooley M&A

OCTOBER 29, 2018

M&A practitioners have long advised boards of directors that the Delaware courts have never found that the events or circumstances in a particular transaction met the contractual standard of having a material adverse effect (or MAE) as defined in a merger or acquisition agreement. The Merger Agreement. 2018-0300-JTL (Del.

Mergers and Acquisitions 52

Mergers and Acquisitions Mergers Business Pharmaceutical 52

OfficeHours

JANUARY 26, 2024

Some dealmakers claim the impact of elections on mergers and acquisitions is minimal. billion acquisition of Qualtrics International Inc. Veterinary pharmaceuticals firm Dechra Pharmaceuticals Plc , which EQT agreed to buy for around £4.5 and Permira’s €14 billion ($15.2 billion ($5.7

Private Equity 130

Private Equity Equities Mergers and Acquisitions Investors 130

Cooley M&A

JANUARY 25, 2023

But it wasn’t all carve outs and concerned investors – even with the headwinds in the industry and beyond, there were still several traditional public M&A deals involving biotechnology or medical device companies, as large pharmaceutical companies continued to have cash to deploy for acquisitions.

M&A 40

M&A Mergers and Acquisitions Pharmaceutical Collaboration 40

Cooley M&A

FEBRUARY 8, 2018

No longer just “acquihires,” today’s innovation-driven acquisition is focused on talent retention. One familiar technique used by sophisticated tech buyers is a holdback structure that subjects a portion of key employees’ merger consideration to revesting. The typical revesting period for these arrangements is 24 to 36 months.

M&A 52

M&A Mergers and Acquisitions Mergers Negotiation 52

Peak Frameworks

SEPTEMBER 19, 2023

For example, while a pharmaceutical company focused solely on shareholder value might prioritize high-margin drugs for rare conditions, a stakeholder-oriented approach might consider affordability and broader societal health needs , as seen with Gilead's approach to its HIV medications.

Corporation 52

Corporation Private Equity Mergers and Acquisitions Corporate Finance 52

The New York Times: Mergers, Acquisitions and Dive

OCTOBER 16, 2023

The pharmacy chain, one of the country’s largest, faces more than a thousand lawsuits that say it filled illegal prescriptions for painkillers.

Sale 145

Sale IT Mergers and Acquisitions Pharmaceutical 145

The New York Times: Mergers, Acquisitions and Dive

DECEMBER 18, 2023

Students and parent volunteers from a school in Washington State said in a lawsuit that they had become sick after being exposed to chemicals known as P.C.B.s. that had dripped from light fixtures.

Mergers and Acquisitions 105

Mergers and Acquisitions Pharmaceutical Acquisitions Mergers 105

Software Equity Group

JUNE 6, 2023

 Ideagen is a leading provider of software solutions to regulated and high-compliance industries, including pharmaceutical, aerospace and defense, and life sciences. The Tritan-Ideagen deal demonstrates the value of strategic acquisitions as a method for entering new markets and expanding globally.

M&A 52

M&A Mergers and Acquisitions Middle Market Acquisitions 52

Mergers and Inquisitions

NOVEMBER 1, 2023

PE firms view these companies as especially appealing since low multiples mean they can use higher debt percentages to fund the acquisitions. Fragmented Markets with Many Add-On Acquisition Opportunities – Private equity firms have been snapping up specialist physician practices in the U.S.

Private Equity 59

Private Equity Healthcare Equities Middle Market 59

The Guardian: Mergers & Acquisitions

DECEMBER 12, 2023

Britain’s biggest drugmaker acquires Seattle-based firm Icosavax, expanding vaccine and immune therapy business AstraZeneca is buying its first vaccine company in a $1.1bn deal that will expand the vaccine and immune therapy business it set up during the Covid-19 pandemic.

Business 76

Business IT Mergers and Acquisitions Pharmaceutical 76

The New York Times: Mergers, Acquisitions and Dive

DECEMBER 22, 2023

The deal is a bet on the growing market for psychiatric and neurological drugs.

Mergers and Acquisitions 74

Mergers and Acquisitions Pharmaceutical Food Acquisitions 74

Sun Acquisitions

AUGUST 22, 2024

To mitigate these risks and build more resilient supply chains, companies are increasingly turning to strategic mergers and acquisitions (M&A). Strategic mergers and acquisitions offer a powerful tool to build more resilient supply chains.

M&A 52

M&A Management Mergers and Acquisitions Food 52

The New York Times: Mergers, Acquisitions and Dive

MAY 16, 2023

The Federal Trade Commission said the deal would enable Amgen to “entrench” the monopoly positions of two Horizon drugs that lack competition.

Trading 57

Trading Mergers and Acquisitions Pharmaceutical Acquisitions 57

The Deal

NOVEMBER 19, 2023

While the issue has been intensifying over the past decade, in July the Biden administration proposed new merger guidelines to further protect competition. Additional considerations include how the DOJ and FTC are evaluating transactions including consent decrees, remedy acceptance and merger challenges, Macy said.

M&A 59

M&A Mergers Pharmaceutical IT 59

Cooley M&A

APRIL 7, 2017

The term “indication” is often used in the biotech/pharmaceutical industry as a term of art, and to describe both developmental as well as commercial milestone events in an acquisition agreement. Throughout the trial, it was evident that the word had various meanings during the negotiations.

Mergers and Acquisitions 40

Mergers and Acquisitions Negotiation Pharmaceutical IT 40

M&A Leadership Council

AUGUST 15, 2022

Few companies divest units immediately following an acquisition (unless they are compelled to do so by antitrust regulators), but many companies divest them eventually. In any given year, nearly half of the acquisitions that occur come about because the sellers are divesting a company unit. Sometimes spin-offs precede mergers.

Mergers and Acquisitions 52

Mergers and Acquisitions IPO M&A Initial Public Offering 52

Cooley M&A

JANUARY 22, 2021

The second half of the year witnessed a rebound spurred by several multibillion-dollar deals, including Gilead’s acquisition of Immunomedics for nearly $21 billion and AstraZeneca’s proposed acquisition of Alexion Pharmaceuticals for $39 billion. Life Sciences Enters the SPAC Party, But Will Reverse Merger Suitors Join In?

M&A 40

M&A Mergers and Acquisitions Collaboration Mergers 40

Cooley M&A

JULY 21, 2021

Here is a breakdown of the key aspects of the order that affect tech and life sciences companies, and what to expect around the corner: Expect increased merger scrutiny. The White House called for the antitrust agencies to correct course and “challenge prior bad mergers the past administration did not previously challenge.”.

Mergers and Acquisitions 40

Mergers and Acquisitions Mergers Pharmaceutical M&A 40

Cooley M&A

JANUARY 20, 2022

1] Major all-cash acquisitions have followed, such as Arena Pharmaceutical’s agreement to sell to Pfizer for $6.7 1] Major all-cash acquisitions have followed, such as Arena Pharmaceutical’s agreement to sell to Pfizer for $6.7 billion , Acceleron Pharma’s agreement to sell to Merck for $11.5 With COVID?19

M&A 40

M&A Mergers and Acquisitions Pharmaceutical Mergers 40

Devensoft

AUGUST 24, 2023

By melding the proficiencies, assets, and potentials residing within distinct business sectors or entities under a single organizational umbrella, the practice of mergers and acquisitions unveils dormant possibilities, propels inventive evolution, and champions the delivery of unparalleled outcomes. Short on time? Limited on time?

Business 52

Business Collaboration Mergers and Acquisitions Management 52

Cooley M&A

JANUARY 21, 2022

Procedural upheavals have swept the merger review process, erecting new hurdles that merging parties must leap over, from the “temporary” suspension of early termination to the FTC’s issuance of pre-consummation “warning letters.” Increasing procedural hurdles to merger review. Withdrawal of 2020 Vertical Merger Guidelines.

Mergers and Acquisitions 40

Mergers and Acquisitions Mergers Pharmaceutical IT 40

Cooley M&A

JANUARY 18, 2017

Uncertainty over how vigorous merger enforcement will be in the Trump Administration. The Obama Administration went out with a bang in 2016 on the merger enforcement front in potential reaction to criticism from the left that previous enforcement had been lax. year tenure at the agency. Penn State Hershey.

Mergers and Acquisitions 52

Mergers and Acquisitions Pharmaceutical Mergers Food 52

InvestmentBank.com

MAY 18, 2021

The healthcare industry is formed of numerous subsectors including pharmaceutical services, diagnostics, medical technologies, and managed healthcare. Payor services and pharmaceutical services have generated the most return throughout 2016 and in 1Q 2017. The pharmaceutical industry is valued highly given the performance of buyouts.

Healthcare 40

Healthcare M&A Valuation Hospitality 40